Inventor · disambiguated record
Troy M. Bremer
Also filed as: BREMER TROY · BREMER TROY M
13 granted patents·25 pending applications·94 citations·filing 2001–2023
91Inventor score
Top patents by PatentIndex Score
38 records- 0194US11821900B2Method of selection for treatment of subjects at risk of invasive breast cancerPRELUDE CORP·Filed 2022·Granted Nov 21, 2023·3 cites·13 claims
- 0289US10695000B2Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensorMETRONOM HEALTH INC·Filed 2016·Granted Jun 30, 2020·6 cites·6 claims
- 0386US11439351B2Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensorMETRONOM HEALTH INC·Filed 2018·Granted Sep 13, 2022·4 cites·20 claims
- 0485USD887425SDisplay screen or a portion thereof with graphical user interface depicting daily patterns for analyte monitoringMETRONOM HEALTH INC·Filed 2018·Granted Jun 16, 2020·25 cites·1 claims
- 0584US11543411B2DCIS recurrence and invasive breast cancerPRELUDE CORP·Filed 2015·Granted Jan 3, 2023·4 cites·24 claims
- 0678US8543182B2Implantable biosensor and methods of use thereofBOTVINICK ELLIOT·Filed 2006·Granted Sep 24, 2013·15 cites·15 claims
- 0777US11160474B2Implantable biosensor and methods of use thereofMETRONOM HEALTH INC·Filed 2016·Granted Nov 2, 2021·2 cites·20 claims
- 0874US11553879B2Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensorMETRONOM HEALTH INC·Filed 2016·Granted Jan 17, 2023·1 cites·23 claims
- 0972US9357952B2Implantable biosensor and methods of use thereofMETRONOM HEALTH INC·Filed 2013·Granted Jun 7, 2016·4 cites·15 claims
- 1071US12487242B2DCIS recurrence and invasive breast cancerPRELUDE CORP·Filed 2022·Granted Dec 2, 2025·0 cites·28 claims
- 1171US2022079474A1Implantable biosensor and methods of use thereofMETRONOM HEALTH INC·Filed 2021·Application pending·0 cites
- 1267US7146203B2Implantable biosensor and methods of use thereofBOTVINICK ELLIOT·Filed 2004·Granted Dec 5, 2006·30 cites·48 claims
- 1364US2022187301A1Method of selection for treatment of subjects at risk of invasive breast cancerPRELUDE CORP·Filed 2019·Application pending·0 cites
- 1462US2020352511A1Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensorMETRONOM HEALTH INC·Filed 2020·Application pending·0 cites
- 1561US2025273346A1Identification and methods of treatment of breast cancerPRELUDE CORP·Filed 2023·Application pending·0 cites
- 1660US2005181386A1Diagnostic markers of cardiovascular illness and methods of use thereofFiled 2004·Application pending·0 cites
- 1760US2005069936A1Diagnostic markers of depression treatment and methods of use thereofFiled 2004·Application pending·0 cites
- 1857US2022378339A1Inserter for analyte sensorsMETRONOM HEALTH INC·Filed 2022·Application pending·0 cites
- 1956US2025339058A1Analyte Sensor ApplicatorMETRONOM HEALTH INC·Filed 2023·Application pending·0 cites
- 2053US2021353770A1Delivery of Urea to Cells of the Macula and Retina Using Liposome ConstructsBREMER TROY·Filed 2021·Application pending·0 cites
- 2152US2010069781A1Device and method for accessing and treating ducts of mammary glandsJOHANSEN JERALD A·Filed 2009·Application pending·0 cites
- 2249US2007092888A1Diagnostic markers of hypertension and methods of use thereofDIAMOND CORNELIUS·Filed 2006·Application pending·0 cites
- 2349US2022341936A1Pd-l1 as a predictive marker for therapy in cancerPRELUDE CORP·Filed 2022·Application pending·0 cites
- 2448US11389089B2Inserter for analyte sensorsMETRONOM HEALTH INC·Filed 2018·Granted Jul 19, 2022·0 cites·17 claims
- 2547US2023392209A1Methods for treating a subject with local invasive breast cancer based on pdgfrb levelsPRELUDE CORP·Filed 2021·Application pending·0 cites
- 2647US2022323011A1Analyte sensor applicatorMETRONOM HEALTH INC·Filed 2020·Application pending·0 cites
- 2746US2013046171A1Device and method for accessing and treating ducts of mammary glandsJOHANSEN JERALD A·Filed 2012·Application pending·0 cites
- 2845US11052158B2Delivery of urea to cells of the macula and retina using liposome constructsBREMER TROY·Filed 2017·Granted Jul 6, 2021·0 cites·18 claims
- 2945US2023375549A1Pd-1 as a predictive marker for therapy in cancerPRELUDE CORP·Filed 2021·Application pending·0 cites
- 3044US2005176057A1Diagnostic markers of mood disorders and methods of use thereofFiled 2005·Application pending·0 cites
- 3142US2020085349A1Adhesive systems having an aggressive adhesive outer ring along its bottom perimeter and having a low effective modulus of elasticityMETRONOM HEALTH INC·Filed 2017·Application pending·0 cites
- 3241US2009061422A1Diagnostic markers of breast cancer treatment and progression and methods of use thereofLINKE STEVEN P·Filed 2007·Application pending·0 cites
- 3340US2009275057A1Diagnostic markers predictive of outcomes in colorectal cancer treatment and progression and methods of use thereofLINKE STEVEN P·Filed 2007·Application pending·0 cites
- 3438US2004009536A1System and method for predicting adme/tox characteristics of a compoundFiled 2001·Application pending·0 cites
- 3538US2020008719A1Analyte sensors and methods of manufacturing analyte sensorsMETRONOM HEALTH INC·Filed 2018·Application pending·0 cites
- 3637US2006275844A1Diagnostic markers of breast cancer treatment and progression and methods of use thereofLINKE STEVEN P·Filed 2006·Application pending·0 cites
- 3737US2004180322A1Regional intestinal permeability modelFiled 2001·Application pending·0 cites
- 3834US2011307427A1Molecular markers predicting response to adjuvant therapy, or disease progression, in breast cancerLINKE STEVEN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Troy M. Bremer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →